Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. - Wikidata - awgldk - TriplyDB

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.

http://www.wikidata.org/entity/Q33608040

about

Maternal periconceptional occupational pesticide exposure and neural tube defects Genetic, epigenetic, and environmental contributions to neural tube closure Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.Epidemiologic and genetic aspects of spina bifida and other neural tube defects.Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis Identifying women who might benefit from higher doses of folic acid in pregnancy.Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update.Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies Nongenetic risk factors and congenital heart defects.The role of folic acid fortification in neural tube defects: a review.Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity.A Review of Antibiotic Use in Pregnancy.Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model.Use of trimethoprim-sulfamethoxazole during pregnancy and risk of spontaneous abortion: a nested case control study.

P2860

Q23914646-B8A9816A-0DF7-489F-97C0-22C6D17EFDCA Q27015138-FFB660B5-1D03-4E37-BC14-6322D67AF027 Q33827209-481AC126-CA1D-425B-9877-5A770D73FB6D Q34645951-26584724-280F-489D-BAFA-6C529560C172 Q35090697-B37B97C0-1824-4197-B225-329EBDF42ED8 Q35886420-3153BF33-3E81-4469-9659-80D987CE7CEB Q36536655-746646F5-E4F7-481D-8B29-1224A8407B81 Q36635441-D197D539-C2C1-4E3D-9EE8-8363B408257A Q38130429-91E02C60-8C32-432F-BB02-790603CD3E0F Q38134419-449DB105-1591-4BD7-BB91-B4AE745F2BD2 Q38246106-DB99EDD1-6B83-438A-85C3-7F0871E1DAB7 Q38644820-5511EC7A-B73F-43DC-A829-16D557743AB8 Q49260119-41CF5177-419D-4DB2-9DC3-4A3B54A69353 Q50103216-6BB2951C-9E5C-4C3C-AE99-9EACF65ECE3F

P2860

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.

http://www.wikidata.org/entity/Q33608040

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Exposure to folic acid antagon ...... e risk of major malformations.

@ast

Exposure to folic acid antagon ...... e risk of major malformations.

@en

type

label

Exposure to folic acid antagon ...... e risk of major malformations.

@ast

Exposure to folic acid antagon ...... e risk of major malformations.

@en

prefLabel

Exposure to folic acid antagon ...... e risk of major malformations.

@ast

Exposure to folic acid antagon ...... e risk of major malformations.

@en

P1433

Q33608040-0EA88B60-440E-438D-8BD3-5D4D94455D19

P1476

Q33608040-85E48A2B-9B83-4506-98C4-A77D7898ACC9

P2093

Q33608040-9EBAB791-DC69-4D3E-BD77-9E8D33E57661

Q33608040-BF53FE10-4D20-47E9-9ECE-67D09C9EF45C

Q33608040-D628A12F-C438-40FE-8B35-E8553661822E

Q33608040-E16C848B-A5EC-4585-A868-98860813DA8F

Q33608040-E2743A30-88DB-4520-8279-391461A02825

Q33608040-ED5831B4-860C-4790-A201-52A4B0F7F44C

P2860

Q33608040-06EA7675-8256-4A1D-898F-5DF2039DF3A4

Q33608040-26D91830-3E74-42A0-B162-ADA3C9522DE2

Q33608040-2FB8CED4-84FA-448E-A2D2-CBA71364D4ED

Q33608040-32F0B04A-0F92-410C-94F3-8025FBA57DE3

Q33608040-54102054-D3D3-4534-956B-8F7D4318C389

Q33608040-6605CCB0-CDC0-4366-8D32-298707A58AC0

Q33608040-735C2DCB-2784-42EA-BA06-2248B4FBCCC4

Q33608040-81C474AA-7189-49A6-A36B-4DA97A2A29B2

Q33608040-917E37A3-EA28-45C1-AB62-695EC6D7BD50

Q33608040-9A758AF9-C6E1-4091-AC4A-8F4555870140

P304

Q33608040-0683D293-B93A-4833-8C8C-42CC404D7F47

P31

Q33608040-75951E5E-933D-4859-A899-7D919C5AD35B

P356

Q33608040-0D2F4CED-AA23-463E-9262-AADF90337DED

P407

Q33608040-94D63F0B-0BEE-496E-A3E1-2D441D6FAF26

P433

Q33608040-CA6C7F49-ED08-40F2-BF9F-23E1FF335F0E

P478

Q33608040-665D970E-4BF5-4412-BBF2-D103C62E2C20

P50

Q33608040-4E0C490B-348D-44AF-A3F2-E45E5820C580

P577

Q33608040-A71575F8-986E-4918-9EFD-B10BCC269935

P5875

Q33608040-68B0502A-3F4D-48E6-89D4-0C10D8B61271

P698

Q33608040-CA6B240C-52CB-4853-AFAE-32B9E9E4489F

P932

Q33608040-D2E0402C-8E17-414F-A226-C9FEB36F4636

P356

J.1365-2125.2009.03544.X

P1433

British Journal of Clinical Pharmacology

P1476

Exposure to folic acid antagon ...... e risk of major malformations.

@en

P2093

Amalia Levy

http://www.w3.org/2001/XMLSchema#string

Arnon Wiznitzer

http://www.w3.org/2001/XMLSchema#string

Daniella Landau

http://www.w3.org/2001/XMLSchema#string

Gideon Koren

http://www.w3.org/2001/XMLSchema#string

Ilan Matok

http://www.w3.org/2001/XMLSchema#string

Rafael Gorodischer

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group.

Use of Medicaid data for pharmacoepidemiology.

Folic acid antagonists during pregnancy and the risk of birth defects.

The safety of metoclopramide use in the first trimester of pregnancy.

The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis.

Effects of antibacterials on the unborn child: what is known and how should this influence prescribing.

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of N

Birth defects and parental consanguinity in Norway.

The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention.

Drugs and folate metabolism.

P304

956-962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2009.03544.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Rafael Gorodischer

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40680008

http://www.w3.org/2001/XMLSchema#string

P698

20002091

http://www.w3.org/2001/XMLSchema#string

P932

2810808

http://www.w3.org/2001/XMLSchema#string